Hypertension treatment company Kona Medical wins backing of unnamed medical technology company as well as venture firms including Essex Woodlands and Morgenthaler Ventures.
An unnamed large cap medical technology company has helped US-based hypertension treatment company Kona Medical raise $30m.
The medical technology company was joined by venture firms Essex Woodlands, Domain Associates, Morgenthaler Ventures and BioStar Ventures in the series C round. The company added John Bowers, former senior vice president at SonoSite, had become chief operating officer.
Kona is developing an ultrasound treatment of hypertension, which involves ablation, or removal, of renal nerves, that play a role in determining blood pressure.
Kona said in its filing with the Securities and Exchange Commission the C round could go up to $45m.
The company’s previously raised $10.9m according to an amended filing in 2011.
It also raised a total of $2.8m in 2010, according to two other filings.